Oxidative Stress and MicroRNAs in Vascular Diseases
Overview
Chemistry
Molecular Biology
Affiliations
Oxidative stress has been demonstrated to play a causal role in different vascular diseases, such as hypertension, diabetic vasculopathy, hypercholesterolemia and atherosclerosis. Indeed, increased reactive oxygen species (ROS) production is known to impair endothelial and vascular smooth muscle cell functions, contributing to the development of cardiovascular diseases. MicroRNAs (miRNAs) are non-coding RNA molecules that modulate the stability and/or the translational efficiency of target messenger RNAs. They have been shown to be modulated in most biological processes, including in cellular responses to redox imbalance. In particular, miR-200 family members play a crucial role in oxidative-stress dependent endothelial dysfunction, as well as in cardiovascular complications of diabetes and obesity. In addition, different miRNAs, such as miR-210, have been demonstrated to play a key role in mitochondrial metabolism, therefore modulating ROS production and sensitivity. In this review, we will discuss miRNAs modulated by ROS or involved in ROS production, and implicated in vascular diseases in which redox imbalance has a pathogenetic role.
Exploring the Effects of Metformin on the Body via the Urine Proteome.
Chen Y, Wang H, Yang M, Shen Z, Gao Y Biomolecules. 2025; 15(2).
PMID: 40001544 PMC: 11853151. DOI: 10.3390/biom15020241.
miR-200c inhibition and catalase accelerate diabetic wound healing.
DAgostino M, Sileno S, Lulli D, De Luca N, Scarponi C, Teson M J Biomed Sci. 2025; 32(1):21.
PMID: 39948670 PMC: 11827459. DOI: 10.1186/s12929-024-01113-7.
Zhou H, Zhou J, Liu S, Niu J, Pan J, Li R Redox Biol. 2025; 80:103508.
PMID: 39908863 PMC: 11847473. DOI: 10.1016/j.redox.2025.103508.
Crosstalk Between Oxidative Stress and Epigenetics: Unveiling New Biomarkers in Human Infertility.
Dutta S, Sengupta P, Mottola F, Das S, Hussain A, Ashour A Cells. 2024; 13(22).
PMID: 39594595 PMC: 11593296. DOI: 10.3390/cells13221846.
Molecular Basis of Cardiomyopathies in Type 2 Diabetes.
Giardinelli S, Meliota G, Mentino D, DAmato G, Faienza M Int J Mol Sci. 2024; 25(15).
PMID: 39125850 PMC: 11313011. DOI: 10.3390/ijms25158280.